Liu GS - Search Results

1

Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.

Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Tsai CH, et al. Among authors: liu gs. Int J Mol Sci. 2018 Sep 19;19(9):2830. doi: 10.3390/ijms19092830. Int J Mol Sci. 2018. PMID: 30235809 Free PMC article. Review.

2

Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.

Shen HH, Chan EC, Lee JH, Bee YS, Lin TW, Dusting GJ, Liu GS. Shen HH, et al. Among authors: liu gs. Nanomedicine (Lond). 2015;10(13):2093-107. doi: 10.2217/nnm.15.47. Epub 2015 Jun 22. Nanomedicine (Lond). 2015. PMID: 26096379 Review.

3

Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.

Chang CY, Wang MC, Miyagawa T, Chen ZY, Lin FH, Chen KH, Liu GS, Tseng CL. Chang CY, et al. Among authors: liu gs. Int J Nanomedicine. 2016 Dec 30;12:279-294. doi: 10.2147/IJN.S114754. eCollection 2017. Int J Nanomedicine. 2016. PMID: 28115846 Free PMC article.

4

Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain.

Bee YS, Ma YL, Chen J, Tsai PJ, Sheu SJ, Lin HC, Huang H, Liu GS, Tai MH. Bee YS, et al. Among authors: liu gs. Int J Mol Sci. 2018 Sep 30;19(10):2993. doi: 10.3390/ijms19102993. Int J Mol Sci. 2018. PMID: 30274378 Free PMC article.

5

Proteomics reveals ablation of PlGF increases antioxidant and neuroprotective proteins in the diabetic mouse retina.

Saddala MS, Lennikov A, Grab DJ, Liu GS, Tang S, Huang H. Saddala MS, et al. Among authors: liu gs. Sci Rep. 2018 Nov 13;8(1):16728. doi: 10.1038/s41598-018-34955-x. Sci Rep. 2018. PMID: 30425286 Free PMC article.

6

Development of Kaempferol-Loaded Gelatin Nanoparticles for the Treatment of Corneal Neovascularization in Mice.

Chuang YL, Fang HW, Ajitsaria A, Chen KH, Su CY, Liu GS, Tseng CL. Chuang YL, et al. Among authors: liu gs. Pharmaceutics. 2019 Nov 28;11(12):635. doi: 10.3390/pharmaceutics11120635. Pharmaceutics. 2019. PMID: 31795237 Free PMC article.

7

Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization Via Inhibition of VEGF Production.

Miyagawa T, Chen ZY, Chang CY, Chen KH, Wang YK, Liu GS, Tseng CL. Miyagawa T, et al. Among authors: liu gs. Pharmaceutics. 2020 Apr 28;12(5):404. doi: 10.3390/pharmaceutics12050404. Pharmaceutics. 2020. PMID: 32354067 Free PMC article.

8

Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.

Lin FL, Wang PY, Chuang YF, Wang JH, Wong VHY, Bui BV, Liu GS. Lin FL, et al. Among authors: liu gs. Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30. Mol Ther. 2020. PMID: 32649860 Free PMC article. Review.

9

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.

Chuang YF, Phipps AJ, Lin FL, Hecht V, Hewitt AW, Wang PY, Liu GS. Chuang YF, et al. Among authors: liu gs. Cell Mol Life Sci. 2021 Mar;78(6):2683-2708. doi: 10.1007/s00018-020-03725-2. Epub 2021 Jan 3. Cell Mol Life Sci. 2021. PMID: 33388855 Free PMC article. Review.

10

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing.

Chuang YF, Wang PY, Kumar S, Lama S, Lin FL, Liu GS. Chuang YF, et al. Among authors: liu gs. Front Cell Dev Biol. 2021 Jun 11;9:667879. doi: 10.3389/fcell.2021.667879. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34178991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters